ESC Congress 2026 Abstract

Low cholesterol death risk is tied to nutrition and immune health

In an observational study of 310,160 adults followed for a median 13.5 years, death risks linked to low cholesterol lessened in people with better nutritional and immune health.

Paper by L Li, J Li, H Liu, 4 more authorsQ Yang · Tianjin Medical University General Hospital
Cohort study of 310,160 adults without baseline cardiovascular disease, median 13.5 yearsPopulations

Limit: Underlying malnutrition and inflammation could explain the low-cholesterol mortality link

Edited by Boris Djordjevic · AgingResearch.News

Follow

Researchers tracked 310,160 adults with a median age of 56.1 years and no baseline cardiovascular disease in an observational cohort study using UK Biobank data. Over a median follow-up of 13.5 years, 21,899 participants died, including 3,831 from cardiovascular disease and 18,068 from other causes. The researchers assessed low-density lipoprotein cholesterol, a blood fat, alongside the prognostic nutritional index, a score of nutritional and immune status.

Lower nutritional-immune scores were associated with higher risks of all mortality outcomes. Lower cholesterol was linked to higher all-cause and non-cardiovascular mortality, while higher cholesterol was associated with higher cardiovascular mortality. All-cause death risk was greatest among participants with both low cholesterol and low nutritional-immune scores. In the highest nutritional-immune group, this excess risk was smaller, and the range of likely values included no difference. Cardiovascular mortality risk was highest among participants with low nutritional-immune scores and high cholesterol.

Why it matters

For understanding survival, the findings suggest interpreting cholesterol-related risk alongside nutritional and immune status in people without cardiovascular disease.

Caveats

As an observational cohort study presented in a conference abstract, the analysis cannot establish cause and effect. The study excluded people with preexisting cardiovascular disease, so its findings may not apply to them.